Lycopodium Ltd
ASX:LYL
Prices of ASX stocks are not being updated. The latest LYL price on Alpha Spread is from Oct 15, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lycopodium Ltd
ASX:LYL
|
AU |
|
Lifecore Biomedical Inc
F:LDE
|
US |
|
I
|
International Bancshares Corp
F:IB4
|
US |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
Q
|
QSI Co Ltd
KOSDAQ:066310
|
KR |
|
W
|
WEYCO Group Inc
NASDAQ:WEYS
|
US |
|
S
|
Stifel Financial Corp
F:2SI
|
US |
|
T
|
TransDigm Group Inc
F:T7D
|
US |
|
C
|
Climb Global Solutions Inc
F:PYA
|
US |
Intrinsic Value
Is LYL undervalued or overvalued?
See the intrinsic value estimate for Lycopodium Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Lycopodium Does
Lycopodium Ltd is an engineering and project-delivery company that helps miners build and run processing plants. It designs mines and mineral plants, manages projects from study work through construction, and supports commissioning so new facilities can start up properly. It also provides related consulting, procurement, and operations support for clients that need technical help across a project’s life.
- Headquarters
- Australia AU
- Employees
- 1 300
- IPO date
- Dec 17, 2004
Lycopodium has a narrow economic moat
Lycopodium Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Earnings Waterfall
Lycopodium Ltd
The intrinsic value for Lycopodium Ltd (LYL) under the Base Case is hidden AUD.
Compared with the last price of 20.75 AUD on Oct 15, the stock appears hidden.
